← Tra cứu cổ phiếu
Viewing Quý 1/2026Latest period →

iShareInvest Research

UPCOM · Quý 1/2026

UPH

Dược phẩm TW 25

Analysis of business results & financial statements · Quý 1/2026

▼ Under pressure

Trailing net profit reached 2.5bn, fell 0.2bn compared with the same period last year. Key positives came from higher gross profit, lower selling expenses, and higher financial income. Offsetting pressure came mainly from higher administrative expenses. Detailed impact is shown below:

See what is changing ↓
P/E
37.80x
P/B
0.61x
EPS
190
BVPS
11,882
ROE
1.6%
ROA
0.7%
Market price
7,200
16 Oct 2026

What Is Changing

On a TTM 2026Q1 basis, UPH is declining across multiple metrics versus the same period, suggesting current pressure is not coming from just one side — profit momentum has been slowing across consecutive periods. More notably, a significant portion of profit is supported by non-core sources, further affecting earnings quality.

Profit bridge

Vs last year · TTM

  1. Gross profit
  2. Selling expenses
  3. Financial income
  4. Administrative expenses
Unit: VND bn. Green bars support profit; red bars reduce profit.

A single data point, or a trajectory?

Latest eight quarters · Quý 1/2026

MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24
Revenue26.046.726.920.518.846.724.429.9
LNST0.61.60.5-0.10.31.20.40.9
Net margin2.14%3.38%1.89%-0.53%1.53%2.58%1.44%2.99%

Revenue

26bn

Net income

1bn

Net margin

2.14%

A closer look at what is happening inside the business

A company's statements are read with the questions that fit its type of business.

01

Is the profit sustainable?

Margins are under pressure while earnings still rely significantly on non-core sources.

What is driving the margin?

●

Net margin stands at 2.11%, broadly flat versus the same period. Supportive factors and pressure points are offsetting one another.

Margin is nearly flat but the underlying components are moving — this is a transitional phase, more time is needed to see the real trend.

Net Margin
2.11%
−0.2pp
Gross Margin
13.99%
+1.1pp
SG&A / Revenue
13.35%
+0.5pp
Non-core / Revenue
2.00%
+0.1pp

TTM YoY · 2025Q1 -> 2026Q1

Financial result is supporting margin

Margin support from financial result remains high (74.6% of PBT) — sustainability should be monitored.

02

Is capital being used efficiently?

Evaluate capital, asset, and working-capital efficiency.

Balance Sheet

●

Balance sheet is exceptionally sound — liabilities at 1.46x equity, with a net cash position equivalent to 0.21x equity.

Inventory ended the period at 191.3bn, roughly 49.3% of total assets.

Over the last 12 months, working capital released 0.1bn of cash, mainly thanks to lower inventories and higher payables. Pressure from higher receivables only partly offset that benefit.

Working Capital Efficiency

▲

Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 6.2 days versus the same period last year. The main moves came from DIO rose 21.2 days, DSO fell 13.8 days, and DPO rose 13.7 days.

Improvement comes mainly from faster inventory turnover — watch whether this trend persists in coming periods.

Cash conversion cycle remains stretched

CCC stands at 795.7 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Inventory turnover is slowing

DIO increased by +21.2 days, suggesting more capital is being tied up in inventories.

DuPont

What drives ROE?

Net margin 2.1% -0.2pp
Asset turnover 0.32x -0.01x
Financial leverage 2.43x +0.01x
ROE 1.6% -0.2pp

ROE is broadly flat at 1.6% — the components are offsetting one another.

03

Is financial risk significant?

Financial risk is low — the company has net cash and CFO reached 7.5bn.

Leverage & Liquidity

▲

Track net leverage, interest coverage, and the liquidity buffer on the balance sheet.

Debt maturity and the cash buffer remain the two key areas to monitor.

Some leverage signals are missing, so the current read should be treated as contextual.

Net Debt / Equity
−0.21x
Interest Coverage
None
Cash / Debt
None
Short-term Debt / Total Debt
None

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

▼

With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 7.5bn in 2025, against investing cash flow of 13.6bn.

Post-investment cash flow was positive +21.1bn. Financing cash flow was positive 0.0bn.

CFO / net income was 1,36 lần.

After spending +0.5bn on fixed-asset investment, the business generated trailing free cash flow of +2.9bn.

Research synthesis

What this reporting period is showing

The business is showing a brighter picture at the headline-earnings level, but what deserves a closer look right now is the quality of that improvement. Reported net profit may look better, but if financial income, other income, or unusually low taxes contribute too much, this is not yet a clean enough growth base to extrapolate further. The main bright spot is balance-sheet flexibility, with net cash/equity at about −0.21x. Even so, the earnings mix still warrants monitoring in upcoming periods, when non-core contribution is 74.6%. The residual risk still sits in working capital is tied up too long in the operating cycle, with CCC extended to 796 days.

  • Improvement: the balance sheet remains flexible, with a net cash position equivalent to 0.21x of equity.
  • Watchpoint: cash flow is currently keeping pace with accounting earnings, with CFO / net income at 1.36x. Even so, net financial result still accounts for 74.6% of PBT, so the earnings mix still needs monitoring.
  • Key risk: working capital remains tied up for too long, with cash cycle at 795.7 days.

Questions for the next period

  1. Durability of revenue growth after the current +0,3% YoY pace.

  2. Ability to hold margins around the current 2.11% level.

  3. Cash-flow quality, with operating cash flow currently at 7.5bn in 2025.

From one stock to the whole portfolio

Where does this stock stand
among the rest of your investments?

Each stock is only one part of the wider picture. Looking at investments side by side makes their contribution, risks and opportunities across the portfolio clearer.

How much does this stock
contribute to the portfolio?

Its weight and influence across the assets held for investment.

Is the portfolio
well balanced?

How holdings, sectors and asset groups are distributed in relation to overall risk.

What other opportunities
or risks may be present?

What becomes visible only when investments are viewed together rather than one ticker at a time.

View my portfolio